William F. McKay,Christopher M. Hobot,Danielle L. Biggs,Katara Shaw,John Myers Zanella,Vanja Margareta King,Stephen Mark Cox,Kathy L. Remsen
申请号：
US14846067
公开号：
US20160022704A1
申请日:
2015.09.04
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Effective treatments of pain and inflammation are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce, prevent or treat inflammation and pain and autoimmune disorders. In various embodiments, fluocinolone formulations may be provided within biodegradable polymers to reduce, prevent or treat sciatic pain and/or inflammation. In various embodiments, prevent transplant rejection for at least twenty-five days. In some embodiments, the pain relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
